New blood thinner may improve dialysis outcomes in sepsis patients
Disease control
Not yet recruiting
This study compares two blood thinners used during continuous dialysis in adults with sepsis and acute kidney injury. About 1,162 participants will receive either nafamostat mesylate or standard citrate anticoagulation. The main goal is to see which approach reduces death, ongoin…
Phase: PHASE4 • Sponsor: Jianfeng Xie • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC